BEAM THERAPEUTICS INC (BEAM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BEAM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BEAM | Director | 60 | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
Chirfi Guindo has served on our board of directors since December 2024. Mr. Guindo has also served as the Chief Marketing Officer for Merck & Co., Inc. since July 2022. He is responsible for leading the development and implementation of Merck & Co. s long-term strategy for the Human Health portfolio spanning oncology, vaccines, pharmaceutical and pipeline products. Prior to this role, Mr. Guindo served as the Executive Vice President of Global Product Strategy and Commercialization for Biogen Inc. from November 2018 to June 2022. Mr. Guindo graduated from Ecole Central de Paris (France) with a degree in engineering and has a master s of business administration from New York University s Stern School of Business. We believe that Mr. Guindo's extensive experience in executive roles in the biotechnology industry qualifies him to serve on our board of directors.